Maria Arantxa Horga
Chief Medical OfficerDr. Maria Arantxa Horga, M.D., has been Chief Medical Officer of Atea Pharmaceuticals, Inc. since January 2021 and served as its Acting Chief Medical Officer since October 2020 until January 2021. Dr. Horga served as Executive Vice President of Clinical Sciences of Atea Pharmaceuticals, Inc. since August 2020 until January 2021. Dr. Horga served as Vice President of Pharmacovigilance and Medical Affairs at Biohaven Pharmaceuticals, Inc. from October 2019 to August 2020. Dr. Horga served as Vice President, Global Head of Clinical Program Execution, Site Head of the Roche NY Innovation Center from July 2017 to August 2019. She served as Global Head of Translational Medicine, Infectious Diseases at F. Hoffmann-La Roche from 2012 to 2016. She began her career in drug discovery and development at Bristol-Myers Squibb where she rose through a series of clinical leadership positions to become Group Director of Global Clinical Research, Virology. She holds an M.D. from the Santander School of Medicine and completed her residency in Pediatrics and a fellowship in Pediatric Infectious Diseases at the Mount Sinai School of Medicine.
Positions
- Company NameAtea Pharmaceuticals, Inc.Stock CodeAVIRPositionChief Medical OfficerColleagues
- JSJean-Pierre SommadossiFounder, Chairman, CEO & President
- AJAndrea J. CorcoranCFO, Executive VP of Legal & Secretary
- JFJohn F. VavrickaChief Commercial Officer
- JMJanet M. J. HammondChief Development Officer
- FMFranklin M. BergerLead Independent Director
- PAPolly A. MurphyIndependent Director
- BGBarbara G. DuncanIndependent Director
- BLBruno LucidiIndependent Director
